Terms: = Colorectal cancer AND Neurokinin AND Treatment
15 results:
1. The combined anti-tumor effects of 5-fluorouracil and neurokinin receptor inhibitor, aprepitant, against colorectal cancer: In vitro and in vivo study.
Alalikhan A; Ebrahimi S; Aliee A; Mirzavi F; Hashemy SI
Med Oncol; 2024 Feb; 41(3):70. PubMed ID: 38340190
[TBL] [Abstract] [Full Text] [Related]
2. The substance P/ neurokinin-1 receptor signaling pathway mediates metastasis in human colorectal SW480 cancer cells.
Golestaneh M; Firoozrai M; Javid H; Hashemy SI
Mol Biol Rep; 2022 Jun; 49(6):4893-4900. PubMed ID: 35429316
[TBL] [Abstract] [Full Text] [Related]
3. Impact of the Oncology Care Model on Use of Supportive Care Medications During cancer treatment.
Brooks GA; Landrum MB; Kapadia NS; Liu PH; Wolf R; Riedel LE; Hsu VD; Jhatakia Parekh S; Simon C; Hassol A; Keating NL
J Clin Oncol; 2022 Jun; 40(16):1763-1771. PubMed ID: 35213212
[TBL] [Abstract] [Full Text] [Related]
4. Pooled analysis of combination antiemetic therapy for chemotherapy-induced nausea and vomiting in patients with colorectal cancer treated with oxaliplatin-based chemotherapy of moderate emetic risk.
Shimokawa M; Hayashi T; Nishimura J; Satoh T; Fukunaga M; Matsui R; Tsuji Y; Mizuki F; Kogawa T
BMC Cancer; 2021 Oct; 21(1):1111. PubMed ID: 34656107
[TBL] [Abstract] [Full Text] [Related]
5. A Novel Mechanism of Endoplasmic Reticulum Stress- and c-Myc-Degradation-Mediated Therapeutic Benefits of Antineurokinin-1 Receptor Drugs in colorectal cancer.
Shi Y; Wang X; Meng Y; Ma J; Zhang Q; Shao G; Wang L; Cheng X; Hong X; Wang Y; Yan Z; Cao Y; Kang J; Fu C
Adv Sci (Weinh); 2021 Nov; 8(21):e2101936. PubMed ID: 34605226
[TBL] [Abstract] [Full Text] [Related]
6. NEPA (netupitant/palonosetron) for the antiemetic prophylaxis of nausea and vomiting induced by chemotherapy (CINV) with Folfirinox and Folfoxiri even during the COVID-19 pandemic: a real-life study.
De Luca R; Volpe C; Mistretta O; Paci R; Ferrera G; Caputo V; Rosati G; Cicero G
Eur Rev Med Pharmacol Sci; 2021 Aug; 25(16):5310-5317. PubMed ID: 34486707
[TBL] [Abstract] [Full Text] [Related]
7. Investigation of the Role of neurokinin-1 Receptor Inhibition Using Aprepitant in the Apoptotic Cell Death through PI3K/Akt/NF-
Ghahremanloo A; Javid H; Afshari AR; Hashemy SI
Biomed Res Int; 2021; 2021():1383878. PubMed ID: 34395609
[TBL] [Abstract] [Full Text] [Related]
8. Evaluation of serum level of substance P and tissue distribution of NK-1 receptor in colorectal cancer.
Lorestani S; Ghahremanloo A; Jangjoo A; Abedi M; Hashemy SI
Mol Biol Rep; 2020 May; 47(5):3469-3474. PubMed ID: 32277443
[TBL] [Abstract] [Full Text] [Related]
9. [Basic and translational research progress of gastrointestinal neuroendocrine neoplasmas].
Song Y; Li X; Song T; Lin G; Chen Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Nov; 19(11):1217-1221. PubMed ID: 27928788
[TBL] [Abstract] [Full Text] [Related]
10. Prescription of Prophylactic Antiemetic Drugs for Patients Receiving Chemotherapy With Minimal and Low Emetic Risk.
Okuyama A; Nakamura F; Higashi T
JAMA Oncol; 2017 Mar; 3(3):344-350. PubMed ID: 27812688
[TBL] [Abstract] [Full Text] [Related]
11. Targeting the neurokinin-1 receptor inhibits growth of human colon cancer cells.
Garnier A; Vykoukal J; Hubertus J; Alt E; von Schweinitz D; Kappler R; Berger M; Ilmer M
Int J Oncol; 2015 Jul; 47(1):151-60. PubMed ID: 25998227
[TBL] [Abstract] [Full Text] [Related]
12. Prevention of chemotherapy-induced nausea and vomiting and the role of neurokinin 1 inhibitors: from guidelines to clinical practice in solid tumors.
Di Maio M; Bria E; Banna GL; Puglisi F; Garassino MC; Lorusso D; Perrone F
Anticancer Drugs; 2013 Feb; 24(2):99-111. PubMed ID: 23165435
[TBL] [Abstract] [Full Text] [Related]
13. Truncated neurokinin-1 receptor is increased in colonic epithelial cells from patients with colitis-associated cancer.
Gillespie E; Leeman SE; Watts LA; Coukos JA; O'Brien MJ; Cerda SR; Farraye FA; Stucchi AF; Becker JM
Proc Natl Acad Sci U S A; 2011 Oct; 108(42):17420-5. PubMed ID: 21969570
[TBL] [Abstract] [Full Text] [Related]
14. [Clinical usefulness of oral aprepitant for alleviation of delayed nausea and vomiting induced by mFOLFOX6--report of a case].
Abe T; Hachiro Y; Kunimoto M
Gan To Kagaku Ryoho; 2010 Dec; 37(13):2933-5. PubMed ID: 21160274
[TBL] [Abstract] [Full Text] [Related]
15. The NK-1 receptor is expressed in human primary gastric and colon adenocarcinomas and is involved in the antitumor action of L-733,060 and the mitogenic action of substance P on human gastrointestinal cancer cell lines.
Rosso M; Robles-Frías MJ; Coveñas R; Salinas-Martín MV; Muñoz M
Tumour Biol; 2008; 29(4):245-54. PubMed ID: 18781096
[TBL] [Abstract] [Full Text] [Related]
